A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease

J Med Life. 2019 Apr-Jun;12(2):113-122. doi: 10.25122/jml-2018-0075.


Ulcerative colitis (UC) and Crohn's disease (CD) are classified as chronic inflammatory bowel diseases (IBD) which have similar symptoms and lead to digestive disorders and inflammation in the digestive system. The reason why they occur is still a mystery. A number of factors can be attributed to the prevalence of CD and UC, some of which include geographical location, inappropriate diet, genetics, and inappropriate immune response. Both diseases are more often diagnosed in urban areas compared to rural areas and both have their own challenges and side effects, but the patients can still have a good quality of life. Given the fact that the prevalence of this disease is higher at younger ages and that it disrupts half the life of the patient, it will, most likely, become a major health problem in the near future, even in developing countries. By reviewing valid scientific resources and evaluating new methods of addressing this disease, the present study aims to provide researchers and patients with new insights into this field and facilitate access to new treatments.

Keywords: Crohn’s disease (CD); IBD treatment; Inflammatory Bowel Disease (IBD); ulcerative colitis (UC).

Publication types

  • Review

MeSH terms

  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / epidemiology
  • Colitis, Ulcerative / prevention & control
  • Colitis, Ulcerative / therapy
  • Crohn Disease / diagnosis
  • Crohn Disease / epidemiology
  • Crohn Disease / prevention & control
  • Crohn Disease / therapy
  • Diet
  • Humans
  • Inflammatory Bowel Diseases / diagnosis*
  • Inflammatory Bowel Diseases / epidemiology
  • Inflammatory Bowel Diseases / prevention & control*
  • Inflammatory Bowel Diseases / therapy
  • Prevalence
  • Quality of Life